Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
Alzheimer's Association

2. Address

Address1
655 15th Street, NW
 Address2
​Suite 500
City
Washington
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mrs.
​Annetha Hall
​2026388665
​ahall@alz.org
5. Senate ID#
​1262-12
7. Client Name Self Check if client is a state or local government or instrumentality
​Alzheimer's Association
6. House ID#
​305260000
TYPE OF REPORT 8. Year
​2025
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​530,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Annetha Hall
 Date
4/21/2025 6:10:05 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

NAPA Reauthorization Act (S. 133 / H.R. 619 - P.L. 118-92)
Alzheimers Accountability and Investment Act (S. 134 / H.R. 620 - P.L. 118-93)
Comprehensive Care for Alzheimers Act (S. 626 / H.R. 1637)
Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406)
BOLD Infrastructure for Alzheimer's Reauthorization Act of 2024 (S. 3775/ H.R. 7218 - P.L. 118-142)
Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (S. 4276/H.R. 7688)
Elizabeth Dole Home Care Act, of 2023 (S. 141 / H.R. 542)
Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (H.R. 8371)
VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10)
Access to Innovative Treatments Act of 2023 (H.R. 2408)
Mandating Exclusive Review of Individual Treatments (MERIT) Act (H.R. 133)
Elder Justice Reauthorization and Modernization Act of 2023 (S. 1198/H.R. 2718)
Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815)
Palliative Care and Hospice Education and Training Act (S. 2243)
Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199)
Supporting Our Seniors Act (S. 2584)
Alleviating Barriers for Caregiving Act (S. 3109)
Credit for Caring Act of 2024 (S. 3702/H.R. 7165)
Credit for Caring Act of 2025 (S. 925/H.R. 2036)
Lifespan Respite Care Reauthorization Act of 2024 (S. 4325/H.R. 6160)
Lifespan Respite Care Reauthorization Act of 2025 (S.830/H.R.2560)
DeOndra Dixon INvestigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome (INCLUDE) Project Act of 2024 (H.R. 7406)
Paid Family and Medical Leave Tax Credit Extension Act (S. 3680)
Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996)
CONNECT for Health Act of 2023 (S. 2016/H.R. 4189)
PACE Part D Choice Act of 2023 (S. 1703/H.R. 3549)
Improving Seniors' Access to Timely Care Act of 2024 (S. 4532/H.R. 8702)
Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act of 2024 (H.R. 9233)
Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 (BENEFIT)(S. 526/H.R. 1092)
Essential Caregivers Act of 2024 (S. 4280/H.R. 8331)
Ensuring Patient Access to Critical Breakthrough Products Act of 2024 (H.R. 1691)
Linking Seniors to Needed Legal Services Act of 2024 (H.R. 8588)
Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1029)
Catching Up Family Caregivers Act of 2024 (S. 5149 / H.R. 9764)
Improving Retirement Security for Family Caregivers Act of 2024 (S. 5148 / H.R. 9765)
Charitable Act (S. 317/H.R. 801)
Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies
Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
Other matters related to care payment models, including the GUIDE model
Other matters related to Medicare care planning code 99483
Other matters related to health care workforce shortages
Other matters related to home- and community-based services
Other matters related to disaster preparedness and older adults
Other matters related to Social Security
Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO)
Other matters related to beta-amyloid PET scans
Other matters related to selected diagnoses and services rendered under ICD-10
Other matters related to caregiving
Other matters related to medical devices
Other matters related to rural health
Other matters related to veterans' health
Other matters related to Tricare
Other matters related to research
Other matters related to biomarkers including blood based tests and cerebral spinal fluid (CSF)
Other matters related to public health

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Federal Emergency Management Agency (FEMA), Social Security Administration (SSA), Government Accountability Office (GAO), Health Resources & Services Administration (HRSA), Food & Drug Administration (FDA), Indian Health Service

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Rachel
Conant
​
​
Sarah
Tellock
​
​
Jennifer
Pollack
​
​
Laura
Thornhill
​
​
Amy
Heath
​
​
Evan
Holler
​
​
Mary
Germiller
​
​
Sarah
Osuna
​
​
Zoe
Salzberg
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Matters related to Fiscal Years 2025 and 2026 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service.
Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research.
Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease.
Other matters related to beta-amyloid PET scans.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Rachel
Conant
​
​
Sarah
Tellock
​
​
Laura
Thornhill
​
​
Jennifer
Pollack
​
​
Evan
Holler
​
​
Mary
Germiller
​
​
Sarah
Osuna
​
​
Zoe
Salzberg
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)